Epredia
Epredia was established in July 2019 through an acquisition by PHC Group from Thermo Fisher Scientific. Powered by trusted brands such as Shandon, Microm, Menzel Gläser and Richard-Allan Scientific, Epredia has a wide breadth of solutions that have and will continue to transform the anatomical pathology market.
Today, we’re a global precision cancer diagnostics company working to improve patient outcomes by providing groundbreaking technologies. Since our humble beginnings in 1937, every product developed has been impacted by generations of employees who are committed to improving lives by enabling pathologists through enhancing precision cancer diagnostics.
At Epredia, our mission is personal and our culture is defined by our passion and care for our employees and our customers. We value a collaborative environment with a winning mentality that delivers operational excellence and best-in-class support to our customers on the frontline. We live and model our Values & Behaviors to inspire our people and make Epredia a world-class organization that we are all proud to claim as part of our identity and the place where we work.